Xlear, Inc., U.S. v.
The FTC, acting through DOJ, sued Xlear, Inc. in October 2021 under the COVID-19 Consumer Protection Act, alleging the Utah-based company falsely marketed its saline nasal sprays as effective for preventing and treating COVID-19. The core violation was unsubstantiated efficacy claims tied to a serious infectious disease. In March 2025, DOJ agreed to dismiss the case with prejudice, resulting in no final judgment or penalty against Xlear.
Flagged claims (1)
falsely pitched its saline nasal sprays as an effective way to prevent and treat COVID-19
Required actions (1)
In March 2025, the DOJ agreed to dismiss the case with prejudice.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWant this watched for you? Free monthly monitoring re-scans your site against the Atlas ruleset and emails you when new flagged wording appears, and your site gets the "Compliance Monitored" seal. Start free monitoring.
Worried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker